19.09.2016 • News • Elaine Burridge • Biesterfeld • bonding

Biesterfeld Sells Rampf’s Resins in Europe

Germany chemicals distributor Biesterfeld has signed an agreement with Rampf Polymer Solutions to market and sell that company’s electro casting resins in selected European countries with immediate effect. The agreed territories include Germany, Austria, Switzerland, Poland, Czech Republic, Slovakia and the Baltic states.

Distributed by Biesterfeld Spezialchemie, the portfolio comprises two-component polyurethane systems (Raku-Pur) and one-/two component epoxy systems (Raku-Pox) with very high thermal resistance. Werner Schwarz, marketing manager performance products at Biesterfeld Spezialchemie, said the partnership enlarges its offering for European customers in the electrical and electronics industry with products tailored to their needs.

Located in Grafenberg, Germany, Rampf Polymer Solutions offers customized casting resin systems for sealing, bonding, casting and coating. Financial terms of the agreement were not disclosed.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Top-Feature

most read

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.